European Companies Search Engine
7 EU fundings (€263,659): Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections … BdlYear 2017 EU Research and Innovation programme "Horizon"
Text
Bolagsverket 5560117482
This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: AstraZeneca AB, Södertälje, Sweden.